Speaker

Rich Edwards

Chief Technology Officer, Nuclide Therapeutics

Rich Edwards, Chief Technology Officer at Nuclide Therapeutics, is speaking at 8th Targeted Radiopharmaceuticals Summit Europe 2026 (London, United Kingdom, 1–3 Dec 2026) in the session “The Great Isotope Debate: Which Therapeutic Radionuclide Will Define the Next 5 Years of TRP Development?”.

Conferences: 1
Keynotes: 0
Upcoming: 1

Upcoming appearances

8th Targeted Radiopharmaceuticals Summit Europe 2026
1–3 Dec 2026London, United Kingdom
- PanelThe Great Isotope Debate: Which Therapeutic Radionuclide Will Define the Next 5 Years of TRP Development?With Chaitanya Divgi, Mohamad Haqiqian, Michael Method, Ajaaz Hussain, Guangzhou Han, Waisi Eng
- PanelRoundtable Discussion: Is Actinium-225 Ready for Mainstream Clinical Adoption? Balancing Scientific Promise with Development Reality

More speakers at 8th Targeted Radiopharmaceuticals Summit Europe 2026

Friedmund Bachmann
Vice President CMC & Project Lead, OncoOne
Luke Brzozowski
Executive Director - Translational Research & Core Facilities ,Program Sponsor, Theranostics, UHN
Frederic Desdouits
Chief Executive Officer, OranoMed
Kemp Dolliver
Director of Research, Brookline Capital Markets
Cara Ferreira
Chief Executive Officer, Lumina Pharmaceuticals
Mark Fielding
Director - Chemistry, Manufacturing, Controls, Regulatory Affairs & Radiopharmaceuticals, AstraZeneca

See all 30 speakers on the event page

This profile is built from conference programmes published on kongre.net. It has not been claimed or confirmed by Rich Edwards, and it lists only the talks, sessions and presentations named in those programmes.

Is this you? Claim this profile — every request is read by a person before anything is linked.

To ask for a correction or for this profile to be removed, email [email protected].